Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes

JAMA

Volumn 310, Issue 8, 2013, Pages 821-828

  Qi, Lu ^a,b   Qi, Qibin ^a   Prudente, Sabrina ^c   Mendonca, Christine ^d   Andreozzi, Francesco ^e   Di Pietro, Natalia ^f   Sturma, Mariella ^g   Novelli, Valeria ^b,d   Mannino, Gaia Chiara ^d,e   Formoso, Gloria ^f   Gervino, Ernest V ^b,h   Hauser, Thomas H ^b,h   Muehlschlegel, Jochen D ^b,i   Niewczas, Monika A ^b,d   Krolewski, Andrzej S ^b,d   Biolo, Gianni ^g   Pandolfi, Assunta ^f   Rimm, Eric ^a,b   Sesti, Giorgio ^e   Trischitta, Vincenzo ^c,j   Hu, Frank ^a,b   Doria, Alessandro ^b,d   more..

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d JOSLIN DIABETES CENTER   (United States)

^e UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^f UNIVERSITY OF CHIETI   (Italy)

^g UNIVERSITY OF TRIESTE   (Italy)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j SAPIENZA UNIVERSITY OF ROME   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTAMINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; CHROMOSOME VARIANT; CONTROLLED STUDY; CORONARY RISK; DISEASE ASSOCIATION; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GLUTAMATE AMMONIA LIGASE GENE; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ZNF648 GENE;

EID: 84883117997     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.276305     Document Type: Article

References (51)

1. International Diabetes Federation. IDF Diabetes Atlas. http://www.idf.org/diabetesatlas/5e/Update2012. Accessed August 6, 2013.
2. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet. 2011;378(9786):169-181.
3. Ford ES, Capewell S. Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care. Annu Rev Public Health. 2011;32:5-22.
4. Polonsky KS. The past 200 years in diabetes. N Engl J Med. 2012;367(14):1332-1340.
5. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004;109(9):1101-1107. (Pubitemid 38332613)
6. Lusis AJ, Mar R, Pajukanta P. Genetics of atherosclerosis. Annu Rev Genomics Hum Genet. 2004;5:189-218. (Pubitemid 39362746)
7. Erdmann J, Grosshennig A, Braund PS, et al Italian Atherosclerosis, Thrombosis, and Vascular Biology Working Group; Myocardial Infarction Genetics Consortium;Wellcome Trust Case Control Consortium; Cardiogenics Consortium. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet. 2009;41(3):280-282.
8. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316(5830):1491-1493. (Pubitemid 46906618)
9. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316(5830):1488-1491. (Pubitemid 46906617)
10. Samani NJ, Erdmann J, Hall AS, et al WTCCC and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357(5):443-453. (Pubitemid 47204873)
11. Schunkert H, König IR, Kathiresan S, et al; Cardiogenics; CARDIoGRAM Consortium. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43(4):333-338.
12. Trégouët DA, König IR, Erdmann J, et al; Wellcome Trust Case Control Consortium; Cardiogenics Consortium. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet. 2009;41(3):283-285.
13. Qi L, Parast L, Cai T, et al. Genetic susceptibility to coronary heart disease in type 2 diabetes. J Am Coll Cardiol. 2011;58(25):2675-2682.
14. Colditz GA, Manson JE, Hankinson SE. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health. 1997;6(1):49-62.
15. Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991;338(8765):464-468.
16. Doria A, Wojcik J, Xu R, et al. Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes. JAMA. 2008;300(20):2389-2397.
17. Bacci S, Ludovico O, Prudente S, et al. The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction. Diabetes. 2005;54(10):3021-3025. (Pubitemid 41401102)
18. Sharma R, Prudente S, Andreozzi F, et al. The type 2 diabetes and insulin-resistance locus near IRS1 is a determinant of HDL cholesterol and triglycerides levels among diabetic subjects. Atherosclerosis. 2011;216(1):157-160.
19. Jensen MK, Pers TH, Dworzynski P, et al. Protein interaction-based genome-wide analysis of incident coronary heart disease. Circ Cardiovasc Genet. 2011;4(5):549-556.
20. Dupuis J, Langenberg C, Prokopenko I, et al DIAGRAM Consortium; GIANT Consortium; Global BPgen Consortium; Anders Hamsten on Behalf of Procardis Consortium; MAGIC Investigators. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42(2):105-116.
21. Saxena R, Hivert MF, Langenberg C, et al GIANT Consortium; MAGIC Investigators. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet. 2010;42(2):142-148.
22. Morris AP, Voight BF, Teslovich TM, et al Wellcome Trust Case Control Consortium; Meta-Analyses of Glucose and Insulin-Related Traits Consortium (MAGIC) Investigators; Genetic Investigation of Anthropometric Traits (GIANT) Consortium; Asian Genetic Epidemiology Network-Type 2 Diabetes (AGEN-T2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981-990.
23. Qi L, Cornelis MC, Kraft P, et al Meta-analysis of Glucose and Insulin-Related Traits Consortium (MAGIC); Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet. 2010;19(13):2706-2715.
24. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol. 2010;34(8):816-834.
25. Gorfien S, Spector A, DeLuca D, Weiss S. Growth and physiological functions of vascular endothelial cells in a new serum-free medium (SFM). Exp Cell Res. 1993;206(2):291-301. (Pubitemid 23212947)
26. Biolo G, Agostini F, Simunic B, et al. Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5 wk of bed rest. Am J Clin Nutr. 2008;88(4):950-958.
27. Aulchenko YS, Struchalin MV, van Duijn CM. ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics. 2010;11:134.
28. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26(17):2190-2191.
29. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188. (Pubitemid 17189972)
30. Qi Q, Meigs JB, Rexrode KM, Hu FB, Qi L. Diabetes genetic predisposition score and cardiovascular complications among patients with type 2 diabetes. Diabetes Care. 2013;36(3):737-739.
31. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006;38(2):209-213. (Pubitemid 43177235)
32. Kathiresan S, Voight BF, Purcell S, et al Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009;41(3):334-341.
33. Assimes TL, Hólm H, Kathiresan S, et al Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium; Cardiogenics. Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol. 2010;56(19):1552-1563.
34. Reilly MP, Li M, He J, et al Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis. Lancet. 2011;377(9763):383-392.
35. Smith NL, Felix JF, Morrison AC, et al. Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. Circ Cardiovasc Genet. 2010;3(3):256-266.
36. Krebs HA. Metabolism of amino-acids: the synthesis of glutamine from glutamic acid and ammonia, and the enzymic hydrolysis of glutamine in animal tissues. Biochem J. 1935;29(8):1951-1969.
37. Meister A, Tate SS. Glutathione and related gamma-glutamyl compounds: biosynthesis and utilization. Annu Rev Biochem. 1976;45:559-604.
38. DeBerardinis RJ, Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 2010;29(3):313-324.
39. Carobbio S, Ishihara H, Fernandez-Pascual S, et al. Insulin secretion profiles are modified by overexpression of glutamate dehydrogenase in pancreatic islets. Diabetologia. 2004;47(2):266-276. (Pubitemid 38315363)
40. Samocha-Bonet D, Wong O, Synnott EL, et al. Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients. J Nutr. 2011;141(7):1233-1238.
41. Greenfield JR, Farooqi IS, Keogh JM, et al. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. Am J Clin Nutr. 2009;89(1):106-113.
42. Lomivorotov VV, Efremov SM, Shmirev VA, et al. Glutamine is cardioprotective in patients with ischemic heart disease following cardiopulmonary bypass. Heart Surg Forum. 2011;14(6):384-388.
43. Sufit A, Weitzel LB, Hamiel C, et al. Pharmacologically dosed oral glutamine reduces myocardial injury in patients undergoing cardiac surgery: a randomized pilot feasibility trial. JPEN J Parenter Enteral Nutr. 2012;36(5):556-561.
44. Cheng S, Rhee EP, Larson MG, et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation. 2012;125(18):2222-2231.
45. Lauzier B, Vaillant F, Merlen C, et al. Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathway. J Mol Cell Cardiol. 2013;55:92-100.
46. Newsholme P, Krause M. Nutritional regulation of insulin secretion: implications for diabetes. Clin Biochem Rev. 2012;33(2):35-47.
47. Yoshida K, Hirokawa J, Tagami S, et al. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus. Diabetologia. 1995;38(2):201-210.
48. Suhre K, Shin SY, Petersen AK, et al CARDIoGRAM. Human metabolic individuality in biomedical and pharmaceutical research. Nature. 2011;477(7362):54-60.
49. von Schacky C. n-3 Fatty acids and the prevention of coronary atherosclerosis. Am J Clin Nutr. 2000;71(1)(suppl):224S-227S.
50. Schmitz G, Ruebsaamen K. Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis. 2010;208(1):10-18.
51. Holmans P, Green EK, Pahwa JS, et al Wellcome Trust Case-Control Consortium. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet. 2009;85(1):13-24.